al • da • tu [ɒl - də - tu]: to become something different

Aldatu Biosciences Navigation
  • OUR PRODUCTS
    • HIV Drug Resistance
    • Lassa Fever Virus
    • SARS-CoV-2
    • Enzymes – Hot Start RT
  • TECHNOLOGY
  • OUR STORY
  • NEWS
  • Search
  • 0 Items
  • OUR PRODUCTS
    • HIV Drug Resistance
    • Lassa Fever Virus
    • SARS-CoV-2
    • Enzymes – Hot Start RT
  • TECHNOLOGY
  • OUR STORY
  • NEWS
  • Search
  • 0 Items

Post Archive by Month

Below you'll find a list of all posts from March, 2015

Aldatu Biosciences Receives $1.5 Million Direct-to-Phase II SBIR Grant from the NIAID for HIV Drug Resistance Diagnostic Development

Cambridge, MA, 12th March 2015 (download press release .pdf) Aldatu Biosciences, a novel diagnostics platform company focused on improving HIV patient care globally, today announced it has been awarded a Direct-to-Phase …

Read More

ACCOUNT

  • Sign up
  • Login

OUR COMPANY

  • Products
  • Our Story
  • Technology

RESOURCES

  • News
  • Contact
  • Terms and Conditions
Facebook-f
Twitter
Linkedin-in

© 2021 ALDATU BIOSCIENCES 2021.

Aldatu HQ

Contact Us

Aldatu Biosciences, 127 Western Ave, Harvard Life Lab, Boston MA 02134


Email: change@aldatubio.com


For career and internship opportunities, please click here.

Toggle the Widgetbar